News
Category
-
PR Newswire
Vanessa Ribreau Joins BenchSci as Chief People Officer to Lead Company’s Embrace of the Future of Work
August 11, 2021 -
PR Newswire
The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director
August 11, 2021 -
PR Newswire
1upHealth Announces Free Baseline Testing for Health Plans to Determine if their Patient Access FHIR® API is Successfully Connecting as Required by CMS
August 11, 2021 -
PR Newswire
Whatfix Closes Nittio Learn Acquisition During Record Quarter in Q2, 2021
August 10, 2021 -
Forbes
Beam Therapeutics Is Aiming To Start Human Trials For Its Sickle Cell Treatment
August 10, 2021 -
Business Wire
WellAir Appoints Kari Dixon as Chief Financial Officer
August 10, 2021 -
PR Newswire
MaxCyte Signs Clinical and Commercial License with Sana Biotechnology
August 9, 2021 -
PR Newswire
Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas
August 9, 2021 -
GlobeNewswire
Tempest Announces Appointment of Ronit Simantov, M.D. to its Board of Directors
August 9, 2021 -
PR Newswire
Innovent Announces the Establishment of the Scientific Advisory Board
August 8, 2021 -
GlobeNewswire
BenchSci Announces Craig Newell as New Chief Architect Officer as it Broadens Biomedical AI Platform
August 6, 2021 -
PR Newswire
EY Announces Nick Culbertson of Protenus as an Entrepreneur Of The Year® 2021 Mid-Atlantic Award Winner
August 5, 2021 -
PR Newswire
Insilico Medicine and Usynova Announce Strategic Partnership on Accelerating R&D of Small Molecule Innovative Drugs with AI
August 5, 2021 -
PR Newswire
Health Payment Systems, Inc. Names Centivo as a Third-Party Administrator for BHCG Member-Employers
August 4, 2021 -
FierceBiotech
Insilico Medicine’s AI engines continue to churn out new drug candidates, now in kidney fibrosis
August 4, 2021 -
PR Newswire
Buoy Health Publishes White Paper on Post-Pandemic Transformation of U.S. Healthcare Navigation
August 3, 2021 -
PR Newswire
Insilico Medicine and Westlake Pharma Announce Cooperation Relationship on Accelerating the Innovative Drugs R&D for Novel Coronavirus
August 2, 2021 -
GlobeNewswire
Cytek Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 2, 2021 -
Business Wire
Rallybio Corporation Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
August 2, 2021 -
Venture Beat
MoEngage raises $32.5M to inject customer engagement with AI
July 30, 2021 -
GlobeNewswire
Flywire Digitizes Education Payments for LaLiga Business School
July 28, 2021 -
PR Newswire
BenchSci Extends Impact on Drug Discovery With Addition of AI-Assisted Animal Model Selection
July 28, 2021 -
Fierce Healthcare
Behavioral health matchmaker SonderMind hits unicorn status with $150M series C
July 28, 2021 -
PR Newswire
AvantStay Continues Market Expansion and Rapid Portfolio Growth Offering 600+ Homes Across the United States
July 27, 2021 -
GlobeNewswire
Cytek Biosciences Announces Closing of Its Initial Public Offering
July 27, 2021 -
PR Newswire
RareStone Inc. Announces Strategic Collaboration with Tencent on a Service Ecosystem Focused on Rare Disease Patients in China
July 27, 2021 -
Business Wire
LTC ACO Selects PatientPing’s Real-Time E-Notification System to Improve Patient Outcomes and Lower Total Cost of Care for Medicare Beneficiaries Across the Healthcare Continuum
July 27, 2021 -
PR Newswire
Embark Veterinary Announces $75M Series B Funding Led by SoftBank Vision Fund 2
July 26, 2021 -
GlobeNewswire
Denali Therapeutics Announces Positive Interim Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with the Lysosomal Storage Disease Hunter Syndrome (MPS II)
July 25, 2021 -
PR Newswire
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT Bispecific Antibody) in Patients with Advanced Malignant Tumors
July 25, 2021 -
Renaissance Capital Report
Cell analysis instruments provider Cytek BioSciences prices upsized IPO at $17 midpoint
July 24, 2021 -
BioPharma Dive
Caribou raises $304M in one of gene editing’s most lucrative IPOs
July 23, 2021 -
Forbes
Warmly Launches Free App For Zoom, Announces Fresh $2.4 Million In Additional Funding
July 22, 2021 -
Nasdaq
Rare disease biotech Rallybio sets terms for $81 million IPO
July 22, 2021 -
GlobeNewswire
Adagene Announces Clinical Trial Collaboration With Merck to Advance Two Anti-CTLA-4 Monoclonal Antibody Programs (ADG116 and ADG126) in Combination Therapy with KEYTRUDA® (pembrolizumab)
July 22, 2021 -
PR Newswire
RareStone Inc. Announces Submission of New Drug Application (NDA) of Wakix® (pitolisant) for narcolepsy with and without cataplexy in China
July 21, 2021 -
GlobeNewswire
Coherus BioSciences Names Physician-Scientist Ildiko Csiki, M.D., Ph.D., Chair of its Scientific Advisory Board
July 21, 2021 -
PR Web
Vestwell Raises $70 Million in Series C Funding, Led by Wells Fargo Strategic Capital and Fin Venture Capital
July 20, 2021 -
GlobeNewswire
Affinia Therapeutics Announces Collaboration with the Institute of Molecular and Clinical Ophthalmology Basel (IOB) To Rationally Design Novel CNS Promoters for Gene Therapy
July 20, 2021 -
PR Newswire
GenFleet Therapeutics and Insilico Medicine Announce Strategic Partnership
July 20, 2021 -
Business Wire
AtlantiCare Expands Consumer Self-Service with Digital Access Solutions from Kyruus
July 20, 2021 -
Endpoints News
As its next big bet, Sana inks long-term lease for manufacturing site for next-gen cell therapies
July 15, 2021 -
PR Newswire
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI319 (Anti-PD-1/CD137 Bispecific Antibody) in Patients with Advanced Malignant Tumors
July 15, 2021 -
PR Newswire
Innovent and Ascentage Pharma Reach Multifaceted Strategic Agreement including Joint Commercialization of Olverembatinib in China, Joint Clinical Development on Multiple Products, and Equity Investment
July 14, 2021 -
Business Wire
Devoted Health Announces Maine Office Expansion, Creating at Least 40 New Jobs in Cumberland County
July 14, 2021 -
TechCrunch
Castor, a clinical trial process company, raises $45M to create more human-centered research
July 14, 2021 -
Forbes
Prime Medicine – This Gene Editing Startup Raised $315 Million For A Next Generation Crispr Tool To Cure Rare Diseases
July 13, 2021 -
GlobeNewswire
Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Spain
July 13, 2021 -
Business Wire
Stamford Health Chooses PatientPing’s Route Solution to Achieve E-Notifications CoP Compliance Under CMS’s Interoperability and Patient Access Rule
July 13, 2021 -
PR Newswire
Everest Medicines Announces Strategic Collaboration with Medbanks Health Technology to Develop Innovative Healthcare Service Solutions for Patients in China
July 13, 2021 -
Business Wire
Caribou Biosciences Announces Dosing of First Patient in Phase 1 Clinical Trial Evaluating CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
July 12, 2021 -
Endpoints News
WHO issues new guidelines for gene editing; Doudna-backed Caribou launches its first allogeneic CAR-T trial
July 12, 2021 -
PR Newswire
Innovent Announces NMPA Acceptance of New Drug Application for the FGFR1/2/3 Inhibitor (Pemigatinib) for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
July 8, 2021 -
PR Newswire
Innovent and Laekna Therapeutics Enter a Partnership Agreement to Co-Develop Combination Therapy of Sintilimab and Afuresertib in Clinical Studies in China
July 5, 2021 -
Renaissance Capital Report
Cell analysis instruments provider Cytek BioSciences files for a $100 million IPO
July 2, 2021 -
Business Wire
Rallybio Announces Clinical Proof of Concept for RLYB211, an Anti-HPA-1a Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
July 2, 2021 -
GlobeNewswire
Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US
July 1, 2021 -
MarketWatch
Caribou Biosciences files for IPO to help fund drug studies
July 1, 2021 -
GlobeNewswire
Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema
July 1, 2021 -
GlobeNewswire
Apellis and Beam Therapeutics Enter Exclusive Research Collaboration to Apply Base Editing to Discover Novel Therapies for Complement-Driven Diseases
June 30, 2021 -
GlobeNewswire
Carrot Fertility and RESOLVE Uncover Fertility and Family-Forming Trends in New Fertility at Work Study
June 30, 2021 -
GlobeNewswire
Ultragenyx Appoints Corsee Sanders, Ph.D., to Board of Directors
June 30, 2021 -
Business Wire
Turnstone Biologics Appoints Stewart Abbot, Ph.D., as Chief Scientific Officer
June 29, 2021 -
Business Wire
Precision BioSciences and SpringWorks Therapeutics Dose First Patient in Expanded Phase 1/2a Clinical Trial Evaluating PBCAR269A with Nirogacestat in Patients with Relapsed/Refractory Multiple Myeloma
June 28, 2021 -
PR Newswire
Protenus Announces Nick Culbertson Is an EY Entrepreneur of the Year® 2021 Mid-Atlantic Award Finalist
June 28, 2021 -
PR Newswire
Innovent Announces License Agreement with Synaffix in an ADC Technology Deal
June 28, 2021 -
GlobeNewswire
Denali Therapeutics Announces Initiation of Phase 2 Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in Cutaneous Lupus Erythematosus (CLE) Patients
June 28, 2021 -
PR Newswire
Innovent Announces the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma
June 27, 2021 -
PR Newswire
Innovent Announces the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma
June 27, 2021 -
FierceBiotech
Boston Scientific shells out a hearty $295M for Farapulse’s electric-field-generating afib treatment
June 24, 2021 -
GlobeNewswire
Adela Debuts with $60M in Series A Financing and a Breakthrough Approach to Blood-Based Detection of Cancer and Other Diseases
June 23, 2021 -
PR Newswire
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
June 21, 2021 -
GlobeNewswire
Verve Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 21, 2021 -
Business Wire
Xilio Therapeutics Announces FDA Acceptance of IND Application for XTX101 for the Treatment of Solid Tumors
June 17, 2021 -
Economic Times
PharmEasy valued at $1.8 billion as B Capital buys stake for $20 million
June 17, 2021 -
MarketWatch
Verve Therapeutics shares soar 68% in trading debut
June 17, 2021 -
Business Wire
Zus Health Closes $34M Series A Led by Andreessen Horowitz (a16z); Participation from F-Prime Capital, Maverick Ventures and Others
June 17, 2021 -
PR Newswire
FDA Approves Blueprint Medicines’ AYVAKIT™ (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis
June 16, 2021 -
PR Newswire
Protenus Raises Series D After Doubling Revenue While Reducing Risk for Health Systems
June 15, 2021 -
Business Wire
Beacon Health System Enhances How Patients Find and Schedule Care with Kyruus’ Digital Platform
June 15, 2021 -
PR Newswire
Innovent Announces First Overweight or Obese Subject Dosed in A Phase 2 Clinical Trial of IBI362 (a GLP-1 and Glucagon Receptor Dual Agonist) in China
June 15, 2021 -
Business Wire
Iora Health and Devoted Health Partner in Houston
June 14, 2021 -
Seeking Alpha
Verve Therapeutics Prepares $201 Million IPO
June 14, 2021 -
Business Wire
Equality Health Launches Partnership with Devoted Health
June 14, 2021 -
GlobeNewswire
GeneTx and Ultragenyx Receive Approval from U.K. Regulatory Agency to Begin Clinical Study of GTX-102 for the Treatment of Angelman Syndrome
June 10, 2021 -
TechCrunch
Whatfix nabs $90M to help workers onboard and get the most out of their IT stacks
June 8, 2021 -
One Medical
One Medical Announces Agreement to Acquire Iora Health
June 7, 2021 -
Forbes
Beam Therapeutics Cofounder And Crispr Scientist Publishes Research On New Sickle Cell Treatment In Mice
June 2, 2021 -
PR Newswire
Clinical Trial Results of the BCMA CAR-T Co-developed by Innovent and IASO Biotherapeutics Commented in American Society of Hematology’s Medical Journal “Blood”
June 2, 2021 -
GlobeNewswire
Zenflow Announces $24 Million Financing Round; Appoints Susan Stimson as President
June 2, 2021